NCT00170794View on ClinicalTrials.gov

Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2006

Conditions
Cardiac Transplantation
Interventions
DRUG

Everolimus (RAD001)

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY